Literature DB >> 20394267

Tracheal schwannoma: a misleading entity.

Abdul Latif Hamdan1, Roger V Moukarbel, Ayman Tawil, Mohamad El-Khatib, Ussama Hadi.   

Abstract

Primary tracheal tumors are rare with the majority being malignant. Benign lesions are less frequent with primary tracheal schwannomas accounting for less than 0.5% of tracheal tumors. They are more common in females and their clinical presentation is non-specific. Chronic cough, progressive respiratory distress and even asthma-like conditions prevail as presenting symptoms and signs. Laryngotracheal endoscopy reveals a solitary, well encapsulated mass arising most often from the posterior tracheal wall. The diagnosis of tracheal schwannomas is primarily pathological. Endoscopic excision, sleeve excision or tracheal resection, are all commonly accepted treatment modalities. Proper awareness of these lesions is crucial in the pre-operative work-up of patients presenting with stridor.

Entities:  

Mesh:

Year:  2010        PMID: 20394267

Source DB:  PubMed          Journal:  Middle East J Anaesthesiol        ISSN: 0544-0440


  4 in total

1.  Primary tracheal schwannoma treated by surgical resection: a case report.

Authors:  Ding-Pei Han; Jie Xiang; Zhi-Qiu Ye; Dan-Nong He; Xiao-Chun Fei; Chao-Fu Wang; Jia-Ming Che; Jun-Biao Hang; He-Cheng Li
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Optimal treatment for primary benign intratracheal schwannoma: A case report and review of the literature.

Authors:  Xiahui Ge; Fengfeng Han; Wenbin Guan; Jinyuan Sun; Xuejun Guo
Journal:  Oncol Lett       Date:  2015-07-21       Impact factor: 2.967

3.  Molecular Features of a Primary Transmural Tracheal Schwannoma: Clinical Experience and Review of the Literature.

Authors:  Chunqiu Xia; Minghui Liu; Xiaoyu Niu; Xin Li; Jun Chen
Journal:  Cancer Manag Res       Date:  2022-03-12       Impact factor: 3.989

4.  Treatment of primary tracheal schwannoma with endoscopic resection: A case report.

Authors:  Yong-Shuai Shen; Xiang-Dong Tian; Yi Pan; Hua Li
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.